Anna Mazurek-Kula

Anna Mazurek-Kula

Auto-generated profile, based on publicly available information

Anna Mazurek-Kula

Department of Cardiology, Polish Mother's Memorial Hospital, Research Institute, Poland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2009 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
TMT. Moszura
T. Moszura
AMA. Mazurek-Kula
A. Mazurek-Kula
PDP. Dryzek
P. Dryzek
ASA. Sysa
A. Sysa

26 August 2008 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
TMT. Moszura
T. Moszura
AMA. Mazurek-Kula
A. Mazurek-Kula
PDP. Dryzek
P. Dryzek
JMJ. J. Moll
J. J. Moll
JMJ. A. Moll
J. A. Moll
SQS. A. Qureshi
S. A. Qureshi

12 February 2013 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
TMTomasz Moszura
Tomasz Moszura
PDPawel Dryzek
Pawel Dryzek
SGSebastian Goreczny
Sebastian Goreczny
AMAnna Mazurek-Kula
Anna Mazurek-Kula
JMJacek J. Moll
Jacek J. Moll
SQShakeel A. Qureshi
Shakeel A. Qureshi
Objectives The purpose of this paper is to report our 10 years of experience of interventional treatment of patients with hypoplastic left heart syndrome and to focus on the frequency, type, and results of percutaneous interventions during all the stages of palliation, considering the different techniques, devices, and complications. Background Constant progress in surgical treatment of congenital heart defects in the last decade has significantly improved the prognosis for children with hypoplastic left heart syndrome. However, morbidity and mortality remain relatively high. Modern interventional procedures complement or occasionally replace surgical treatment. Methods Between January, 2001 and December, 2010, 161 percutaneous interventions were performed in 88 patients with hypoplastic left heart syndrome. Patients were divided into four groups: (a) before the first surgical treatment including hybrid approach, (b) after first-stage Norwood operation, (c) after second-stage bidirectional Glenn operation, and (d) after third-stage Fontan operation. Results Percutaneous interventions resulted in statistically significant changes in pulmonary artery pressures, vessel diameters, and O2 saturation. Complications occurred in 4.3% of interventions and were related mainly to stent implantation in stenosed pulmonary arteries. Conclusions Percutaneous interventions may result in haemodynamic stability and reduction in the number of operations. They may result in significant changes in pulmonary artery pressures, vessel diameters, O2 saturation, with a low rate of complications, which are mainly related to stent implantation in the pulmonary arteries.

1 January 2017 in Archives of Medical Science
Verified
Journal Article
Open access
PDF file
SGSebastian Góreczny
Sebastian Góreczny
PDPaweł Dryżek
Paweł Dryżek
GMGareth John Morgan
Gareth John Morgan
AMAnna Mazurek-Kula
Anna Mazurek-Kula
JMJacek J. Moll
Jacek J. Moll
TMTomasz Moszura
Tomasz Moszura
Introduction : Creation of a fenestration during completion of a total cavo-pulmonary connection (TCPC) has been associated with a reduction in early mortality and morbidity. However, the long-term benefits are negated by an associated limitation in exercise tolerance and the potential risks of...

31 October 2023 in Polish Heart Journal
Verified
Journal Article
Open access
PDF file
ECEwa Warchol Celinska
Ewa Warchol Celinska
AMAnna Mazurek-Kula
Anna Mazurek-Kula
PGPatrycja Gladysz-Piestrzynska
Patrycja Gladysz-Piestrzynska
MMMaria Maciejewska-Szabelska
Maria Maciejewska-Szabelska
MŻMałgorzata Żuk
Małgorzata Żuk
PHPiotr Hoffman
Piotr Hoffman
The growing number of adults patients after the Fontan operation requires regular surveillance tests in the specialized centers. Evaluation of current practice of care for Fontan patients in Poland based on a multicenter survey. Eight centers were included in the study-5 adult congenital heart disease (ACHD) and 3 pediatric centers for adolescents. To aim for a comparison between the centers and facilitate the interpretation of the results, the Fontan Surveillance Score (FSS) was developed. The higher score is consistent with better care, with a maximum of 19 points. The number of 398 Fontan patients (243 adults and 155 adolescents [age 14-18 years]) was included in the study. The median FSS was 13 points with variability between the centers (interquartile range 7-14 points). Centers providing continuous care from the pediatric period until 18 years of age achieved a higher FSS compared to ACHD centers (median: 14 points vs 12 points, p< 0.001). Most of the patients, both in the ACHD (82.3%) and in pediatric centers (89%), were seen annually and had a physical examination, electrocardiogram, and echocardiogram performed at each visit. However, unsatisfactory utilization of tests identifying the early stages of Fontan circulation failure (cardiopulmonary exercise tests, cardiac magnetic resonance, liver biochemistry and imaging, detection of protein-losing enteropathy) was observed. The results of the study showed that there is no unified surveillance approach for Fontan patients in Poland. The practice of care for adults differs from that of adolescents.

1 January 2008
Verified
Journal Article
Closed access
PDPaweł Dryzek
Paweł Dryzek
AMAnna Mazurek-Kula
Anna Mazurek-Kula
TMTomasz Moszura
Tomasz Moszura
ASAndrzej Sysa
Andrzej Sysa